MAINPOINTE PHARMACEUTICALS, LLC – Trademark Portfolio
Entity Type: 03
MAINPOINTE PHARMACEUTICALS, LLC holds 20 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 18 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include DR SMITH'S, SLO-NIACIN, THERA-GESIC, and GOES ON LIKE A CREAM. PROTECTS LIKE AN OINTMENT.. The owner is based in LOUISVILLE, KY.
333 EAST MAIN STREET #200
LOUISVILLE, KY 40202
Showing of trademarks Trademarks
Trademark Classifications
MAINPOINTE PHARMACEUTICALS, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does MAINPOINTE PHARMACEUTICALS, LLC have?
MAINPOINTE PHARMACEUTICALS, LLC has 20 U.S. trademarks filed with the USPTO. Of these, 4 registered, 6 abandoned, 10 cancelled.
What trademark classes does MAINPOINTE PHARMACEUTICALS, LLC file in?
MAINPOINTE PHARMACEUTICALS, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are MAINPOINTE PHARMACEUTICALS, LLC's most well-known trademarks?
MAINPOINTE PHARMACEUTICALS, LLC's registered trademark portfolio includes well-known marks such as DR SMITH'S, SLO-NIACIN, THERA-GESIC, and GOES ON LIKE A CREAM. PROTECTS LIKE AN OINTMENT.. These are among 4 currently registered trademarks in the portfolio.
What is MAINPOINTE PHARMACEUTICALS, LLC's trademark registration success rate?
MAINPOINTE PHARMACEUTICALS, LLC has a 20% trademark registration rate, with 4 out of 20 resolved applications resulting in successful registration. Currently, 0 applications are pending review.